Predicting changes in hERG activity is a critical first cardiotoxicity screen, because chemicals that directly or indirectly alter hERG channel activity may affect cardiac action potential, cause QT prolongation, and lead to arrhythmia and/or the more fatal Torsade de pointes condition. Here, KCNH2 is linked to cardiac arrhythmia.